Pfizer Inc. is cutting hundreds of jobs in Switzerland as part of a multi-year program to reduce costs, according to people familiar with the matter. The US drugmaker will reduce its workforce in the ...
American taxpayers spend billions of dollars annually supporting pharmaceutical development. Yet the US continues to pay more for medicine than any other country in the world. This discrepancy so ...
Pfizer Inc. will pay $4.9 billion for the obesity startup Metsera Inc. in a bid to catch up to rival drugmakers after failing to compete with its own weight-loss medications. The US drugmaker agreed ...
Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations. The US drugmaker is offering about 4.55 ...
On this episode of Stock Movers: - Shares of Nike (NKE) moved higher in premarket trading after signs turnaround efforts at the world’s largest sportswear company are starting to pay off. Sales fell 1 ...
On this episode of Stock Movers: -Pfizer shares rise after President Donald Trump said he plans to order cuts to prescription drug costs to bring them in line with other countries. White House ...
A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of blood disorders. The death occurred on Dec. 14 after the patient ...
Pfizer Inc.’s longtime chief scientist is joining Blackstone Inc. to advise the private equity giant on its investments into advanced new medicines. Mikael Dolsten, who retired from Pfizer late last ...
The moment she heard that her mother, then 67, had advanced breast cancer, Stacie Dusetzina began hunting for potential treatments. A cancer policy researcher at Vanderbilt University, Dusetzina knew ...
Pfizer Inc. anunciará planes para reducir los precios de los medicamentos recetados en un evento el martes junto con el presidente Donald Trump, según varios funcionarios de la Casa Blanca. Se prevé ...
On this episode of Stock Movers: - Goldman Sachs (GS) shares are higher after reporting earnings. The big bank approved a $40 billion share buyback program and its 1Q equities trading revenue beat ...
A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid shot data to hurt Donald Trump’s 2020 election prospects, the latest twist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results